IA
EVGN icon

IFP Advisors’s Evogene EVGN Stock Holding History

IFP Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$30.9K – 3065
2020
Q4 		$24K Buy
+500
New +$17.6K ﹤0.01% 1728

Other funds holding EVGN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IFP Advisors's EVGN Position: Q1 2021 in Review

IFP Advisors sold out of Evogene (EVGN) in Q1 2021, closing a stake of 500 shares — an estimated $30.9K sold.

IFP Advisors first reported a position in EVGN in Q4 2020 and held it in 1 quarter. The position peaked at $24K in Q4 2020. 45 funds tracked by Wall St. Rank hold EVGN as of Q1 2021.

  • IFP Advisors reported no remaining Evogene position as of Q1 2021 after selling out during the quarter.
  • IFP Advisors sold 500 Evogene shares in Q1 2021, an estimated $30.9K.
  • IFP Advisors first reported a position in Evogene in Q4 2020 and held it in 1 quarter.
  • IFP Advisors's Evogene position peaked at $24K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Evogene as of Q1 2021.

Based on IFP Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.